Publikationen Archiv - Seite 5 von 8

Vogelmeier, C. F., Diesing, J., Kossack, N., Pignot, M. & Friedrich, F. W. (2021). P631 Risk of future exacerbations among COPD patients – a real-world register-based cohort study in Germany. [Vortrag]. 61. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. G. Rohde, 02.06.2021, Leipzig, digital. DOI:https://doi.org/10.1055/s-0037-1599663 (abgerufen am 01.11.2023).

Therapy areas: Respiratory

Indications: COPD

M. Schultze, A. Marijam, M. Pignot, A. Krinner, N. Kossack, F. Mitrani-Gold, A. Joshi. Patterns and adherence to treatment guidelines by physician speciality in uncomplicated urinary tract infection treatment among female patients in Germany: a retrospective real world study. European Congress of Clinical Microbiology and Infectious Diseases 15-18. April 2023 Copenhagen. No DOI/URL available

Therapy areas: Urology

Indications: Urinary Tract Infection

Kohls, M., Hardt, T., Barck, I., Schultheiss, J., Heidler, T. & Deiters, B. (2019). PCV70 HEALTH CARE COST FOR PATIENTS WITH CHRONIC HEART FAILURE AND IRON DEFICIENCY / ANEMIA BEFORE AND AFTER TREATMENT WITH FERRIC CARBOXYMALTOSE. Value in Health, 22, S. S554. DOI:https://doi.org/10.1016/j.jval.2019.09.795 (abgerufen am 06.11.2023).

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Heart Failure

Hupe, M. C., Hammerer, P., Ketz, M., Kossack, N., Colling, C. & Merseburger, A. S. (2018). PCN96 – INITIAL THERAPY FOR ADVANCED PROSTATE CARCINOMA (PCA) WITH A GNRH AGONIST (GNRHA) AND ANTAGONISTS – A RETROSPECTIVE ANALYSIS OF PRESCRIPTION PATTERNS AND HOSPITAL COSTS BASED ON GERMAN GKV [GESETZLICHE KRANKENVERSICHERUNG (STATUTORY HEALTH INSURANCE)] DATA. Value in Health, 21, Artikel Supplement 3, S. S30-S31. DOI:https://doi.org/10.1016/j.jval.2018.09.178 (abgerufen am 02.11.2023).

Therapy areas: Oncology/Hematology

Indications: Prostate cancer

Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Lisa Elliott, Mercedes Romano Rogdriguez, Nick Freemantle. Long-term real-world effectiveness of allergy immunotherpay in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study. The Lancet Regional Health Volume 13, 100275, FEBRUARY 01, 2022, DOI:https://doi.org/10.1016/j.lanepe.2021.100275

Therapy areas: Immunology

Indications: Allergic Rhinitis, Asthma

Soltmann, B., Neumann, A., March, S., Weinhold, I., Häckl, D., Kliemt, R., Baum, F., Romanos, M., Schwarz, J., Peter, S. von, Ignatyev, Y., Arnold, K., Swart, E., Heinze, M., Schmitt, J. M. & Pfennig, A. (2021). Multiperspective and Multimethod Evaluation of Flexible and Integrative Psychiatric Care Models in Germany: Study Protocol of a Prospective, Controlled Multicenter Observational Study (PsychCare). Frontiers in psychiatry, 12, S. 659773. DOI:https://doi.org/10.3389/fpsyt.2021.659773.

Therapy areas: Psychiatry

Indications: Mental disorders

Birkeland, K. I., Bodegård, J., Banerjee, A., Kim, D. J., Norhammar, A., Eriksson, J. W., Thuresson, M., Okami, S., Ha, K. H., Kossack, N., Mamza, J. B., Zhang, R., Yajima, T., Komuro, I. & Kadowaki, T. (2021). Lower cardiorenal risk with sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study. Diabetes Obes Metab (Diabetes, Obesity and Metabolism), 23(1), S. 75–85. DOI:https://doi.org/10.1111/dom.14189 (abgerufen am 20.10.2023).

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

Baum, F., Schmitt, J. M., Seifert, M., Kliemt, R., Kubat, D., March, S., Häckl, D., Pfennig, A., Swart, E. & Neumann, A. (2022). Lengths of inpatient stay and sick leave of patients with mental diseases: disorder-specific effects of flexible and integrated treatment programs in Germany. Translational psychiatry, 12(370), S. 1–11. DOI:https://doi.org/10.1038/s41398-022-02131-5 (abgerufen am 20.10.2023).

Therapy areas: Psychiatry

Indications: Mental disorders

Häckl, D., Pignot, M. et al. Klinische Verläufe und Kosten für Hospitalisierungen von COVID-19-Patienten mit potenziell eingeschränktem Immunsystem in Deutschland. Deutsche Medizinische Wochenschrift (2024) 149(07):e38-e46. https://DOI:10.1055/a-2239-0453

Therapy areas: Infectious Diseases

Indications: COVID-19

March, S., Zimmermann, L., Kubat, D., Neumann, A., Schmitt, J. M., Baum, F., Schoffer, O., Arnold, K., Seifert, M., Kliemt, R., Häckl, D., Pfennig, A. & Swart, E. (2020). Methodische Herausforderungen bei der Nutzung von Daten von mehr als 70 gesetzlichen Krankenkassen – Ein Werkstattbericht aus der EVA64-Studie. Das Gesundheitswesen, 82(S 01), S. S4-S12. DOI:https://doi.org/10.1055/a-1036-6364 (abgerufen am 30.10.2023).

Therapy areas: Psychiatry

Indications: Mental disorders

Schrom, E., Alexander, T., Schulte, M., Garcia, T. B., Sewerin, P. & Borchert, J. (2023). Incidence, Prevalence and Management of Systemic Lupus Erythematosus in 4 Cohorts: a German Claims Data Analysis. EV.14. In: Deutsche Gesellschaft für Rheumatologie e. V. (Hrsg.). Deutscher Rheumatologiekongress 2023, 30.08–02.09.2023, Leipzig, S. 252. No DOI/URL available

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Horneff, G., Borchert, J., Heinrich, R., Kock, S., Klaus, P., Dally, H., Hagemann, C., Diesing, J. & Schönfelder, T. (2022). Incidence, prevalence, and comorbidities of juvenile idiopathic arthritis in Germany: a retrospective observational cohort health claims database study. Pediatric Rheumatology, 20(100), S. 1–13. DOI:https://doi.org/10.1186/s12969-022-00755-x (abgerufen am 27.10.2023).

Therapy areas: Immunology

Indications: Juvenile idiopathische arthritis

Alexander, T., Schulte, M., Borchert, J., Garcia, T. B. & Schrom, E. (2023). Incidence, Prevalence and Current Treatment Practice of Systemic Lupus Erythematosus: A German Claims Data Analysis. In: J. S. Smolen (Hrsg.). Abstracts. EULAR European Congress of Rheumatology. [Sonderheft]. EULAR 2023 31 May-3 June 2023. Annals of the Rheumatic Diseases, 82(Supplement 1), S. 1450. DOI:https://doi.org/10.1136/annrheumdis-2023-eular.478 (abgerufen am 06.11.2023).

Therapy areas: Immunology

Indications: Systemic Lupus Erythematosus

Kathrin Kahnert, Marija Halbach, Mohammed Dagher, Axel Krinner, Elena Garal-Pantaler, Hana Mullerova, Michael Pollack. Initiation of single- and multiple-inhaler triple therapy for COPD and adoption of budesonide/glycopyrrolate/formoterol (BGF): pooled analysis from the AURA Germany study, European Respiratory Society (ERS) congress. 2024, September 07 - 11, Vienna. No DOI/URL available

Therapy areas: Respiratory

Indications: COPD

Brestrich, G., Hagemann, C., Diesing, J., Kossack, N., Stark, J. H., Pilz, A., Angulo, F. J., Yu, H. & Suess, J. (2024). Incidence of Lyme Borreliosis in Germany: A retrospective observational healthcare claims study. Ticks and tick-borne diseases, 15(3), S. 102326. DOI:https://doi.org/10.1016/j.ttbdis.2024.102326.

Therapy areas: Infectious Diseases

Indications: Lyme Borreliosis

Müller, M., Wuppermann, A., Stahn, G. & Weinhold, I. (2023). Inanspruchnahme von pädiatrischen Präventivleistungen während der COVID-19-Pandemie: Evidenz basierend auf Routinedaten. [Vortrag]. 15. dggö Jahrestagung 2023. Deutsche Gesellschaft für Gesundheitsökonomie e.V., 14.03.2023, Hannover. 04.12.2023). No DOI/URL available

Therapy areas: General Health

Indications: General

Kraus MR, Kleine H, Thönnes S, Pignot M, Sanchez Gonzalez Y. Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther. 2018 Sep;7(3):339-352. doi: 10.1007/s40121-018-0205-2.

Therapy areas: Infectious Diseases

Indications: Hepatitis C

Vogelmeier, C. F., Friedrich, F. W., Timpel, P., Kossack, N., Diesing, J., Pignot, M., Abram, M. & Halbach, M. (2024). Impact of COPD on mortality: An 8-year observational retrospective healthcare claims database cohort study. Respiratory medicine, 222, S. 107506. DOI:https://doi.org/10.1016/j.rmed.2023.107506.

Therapy areas: Respiratory

Indications: COPD

Armin Secker, Marc Pignot, Mohammed Dagher, Nils Kossack, Jason Schwartz, Ana Filipa Alexandre. Iatrogenic Ureteral Injury Rate in Abdominopelvic Surgeries in Germany: Feasibility Assessment Results. RCOG World Congress 2022, ASP5354 No DOI/URL available

Therapy areas: Urology

Indications: Urology, Surgery

Birkeland KI, Bodegard J, Norhammar A, Kuiper JG, Georgiado E, Beekman-Hendriks WL, Thuresson M, Pignot M, Herings RMC, Kooy A. How representative of a general type 2 diabetes population are patients included in cardiovascular outcome trials with SGLT2 inhibitors? A large European observational study. Diabetes Obes Metab. 2019 Apr;21(4):968-974. doi: 10.1111/dom.13612.

Therapy areas: Cardiovascular, Renal and Metabolism

Indications: Diabetes Type 2

1 2 3 4 5 6 7 8

Publikationen

154